ImageneBio, Inc. (IMA) vs Serina Therapeutics, Inc. (SER)
ImageneBio, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. ImageneBio, Inc. and Serina Therapeutics, Inc. are of similar size ($54.4M and $52.9M). ImageneBio, Inc. grew revenue faster over the last twelve months: −68.0% against −94.2%. Across the 14 metrics below, ImageneBio, Inc. leads on 9 and Serina Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | IMA | SER | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (41.34%) | (306.22%) | (57.72%) |
| Return on assets | (38.34%) | (136.00%) | (49.22%) |
| Return on invested capital | (622.37%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack